Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04216186

Role of Coenzyme Q in ADHD in Children

Role of Coenzyme Q in ADHD in Children

Recruiting

Interested in participating?

Request Info

Key information

Conditions

ADHD Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Mental Disorders Neurodevelopmental Disorders

Age range

2 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

About this study

Role of Coenzyme Q in ADHD in Children: will it add a benefit?

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with ADHD

Exclusion criteria

  • Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.

Treatment and study plan

Atomoxetine

Drug

Atomoxetine once daily

Other names: atomox

Coenzyme Q

Drug

Coenzyme Q once daily

Primary outcomes

  1. Number of patients with improved CONNERS scale

    Time frame: 6 months

    The number of patients with improved CONNERS scale

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Sherief Abd-Elsalam

Other

Registry information

Official study title

Role of Coenzyme Q in Treatment of Attention Deficit Hyperactivity Disorder in Children

Important dates

Study start
2018
Primary completion
2030
Study completion
2030
First posted
Jan 2, 2020
Registry last updated
Jan 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.